Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA vs ALBERT DAVID - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ASTRAZENECA PHARMA ALBERT DAVID ASTRAZENECA PHARMA/
ALBERT DAVID
 
P/E (TTM) x 194.7 10.7 1,814.5% View Chart
P/BV x 22.5 1.9 1,171.9% View Chart
Dividend Yield % 0.4 0.9 42.2%  

Financials

 ASTRAZENECA PHARMA   ALBERT DAVID
EQUITY SHARE DATA
    ASTRAZENECA PHARMA
Mar-24
ALBERT DAVID
Mar-24
ASTRAZENECA PHARMA/
ALBERT DAVID
5-Yr Chart
Click to enlarge
High Rs7,2081,605 449.1%   
Low Rs3,102517 600.4%   
Sales per share (Unadj.) Rs518.2634.8 81.6%  
Earnings per share (Unadj.) Rs64.6132.1 48.9%  
Cash flow per share (Unadj.) Rs70.6144.0 49.0%  
Dividends per share (Unadj.) Rs24.0011.50 208.7%  
Avg Dividend yield %0.51.1 42.9%  
Book value per share (Unadj.) Rs283.5670.7 42.3%  
Shares outstanding (eoy) m25.005.71 437.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x9.91.7 595.5%   
Avg P/E ratio x79.88.0 994.0%  
P/CF ratio (eoy) x73.07.4 992.2%  
Price / Book Value ratio x18.21.6 1,150.4%  
Dividend payout %37.18.7 426.9%   
Avg Mkt Cap Rs m128,8756,054 2,128.6%   
No. of employees `000NANA-   
Total wages/salary Rs m2,415884 273.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m12,9553,625 357.4%  
Other income Rs m348576 60.5%   
Total revenues Rs m13,3034,200 316.7%   
Gross profit Rs m2,009470 427.5%  
Depreciation Rs m14968 218.9%   
Interest Rs m124 277.8%   
Profit before tax Rs m2,195973 225.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m580219 265.4%   
Profit after tax Rs m1,615754 214.1%  
Gross profit margin %15.513.0 119.6%  
Effective tax rate %26.422.5 117.6%   
Net profit margin %12.520.8 59.9%  
BALANCE SHEET DATA
Current assets Rs m10,4274,780 218.2%   
Current liabilities Rs m4,6722,054 227.4%   
Net working cap to sales %44.475.2 59.1%  
Current ratio x2.22.3 95.9%  
Inventory Days Days47293 16.1%  
Debtors Days Days43295 14.6%  
Net fixed assets Rs m2,3421,264 185.3%   
Share capital Rs m5057 87.6%   
"Free" reserves Rs m7,0363,773 186.5%   
Net worth Rs m7,0863,830 185.0%   
Long term debt Rs m00-   
Total assets Rs m12,7696,043 211.3%  
Interest coverage x184.0226.2 81.3%   
Debt to equity ratio x00-  
Sales to assets ratio x1.00.6 169.2%   
Return on assets %12.712.6 101.5%  
Return on equity %22.819.7 115.7%  
Return on capital %31.225.5 122.1%  
Exports to sales %07.1 0.0%   
Imports to sales %0.54.0 11.9%   
Exports (fob) Rs mNA257 0.0%   
Imports (cif) Rs m61143 42.5%   
Fx inflow Rs m1,094257 426.3%   
Fx outflow Rs m61143 42.5%   
Net fx Rs m1,033113 912.9%   
CASH FLOW
From Operations Rs m279455 61.3%  
From Investments Rs m217-332 -65.4%  
From Financial Activity Rs m-444-83 536.6%  
Net Cashflow Rs m5240 130.9%  

Share Holding

Indian Promoters % 0.0 62.1 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 8.0 2.5 317.5%  
FIIs % 2.9 0.9 329.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 37.9 66.0%  
Shareholders   27,615 13,590 203.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ASTRAZENECA PHARMA With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on ASTRAZENECA PHARMA vs ALBERT DAVID

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ASTRAZENECA PHARMA vs ALBERT DAVID Share Price Performance

Period ASTRAZENECA PHARMA ALBERT DAVID S&P BSE HEALTHCARE
1-Day 1.46% 0.75% 0.65%
1-Month -11.17% -7.95% -0.82%
1-Year 36.72% 39.62% 42.79%
3-Year CAGR 28.60% 30.59% 20.12%
5-Year CAGR 19.43% 26.05% 26.10%

* Compound Annual Growth Rate

Here are more details on the ASTRAZENECA PHARMA share price and the ALBERT DAVID share price.

Moving on to shareholding structures...

The promoters of ASTRAZENECA PHARMA hold a 75.0% stake in the company. In case of ALBERT DAVID the stake stands at 62.1%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ASTRAZENECA PHARMA and the shareholding pattern of ALBERT DAVID.

Finally, a word on dividends...

In the most recent financial year, ASTRAZENECA PHARMA paid a dividend of Rs 24.0 per share. This amounted to a Dividend Payout ratio of 37.1%.

ALBERT DAVID paid Rs 11.5, and its dividend payout ratio stood at 8.7%.

You may visit here to review the dividend history of ASTRAZENECA PHARMA, and the dividend history of ALBERT DAVID.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Trades Higher | Nifty Above 23,450 | Info Edge & SJVN Jump 5% Sensex Today Trades Higher | Nifty Above 23,450 | Info Edge & SJVN Jump 5%(10:30 am)

Asian markets traded higher on Friday, following the overnight rally on Wall Street, and the release of economic data in the region.